133 related articles for article (PubMed ID: 27977405)
1. Monitoring steroid replacement therapy in children with congenital adrenal hyperplasia.
Birkebaek NH; Hougaard DM; Cohen AS
J Pediatr Endocrinol Metab; 2017 Jan; 30(1):85-88. PubMed ID: 27977405
[TBL] [Abstract][Full Text] [Related]
2. Therapy monitoring in congenital adrenal hyperplasia by dried blood samples.
Wieacker I; Peter M; Borucki K; Empting S; Roehl FW; Mohnike K
J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):867-71. PubMed ID: 25781526
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic/Pharmacodynamic Evaluation of Hydrocortisone Therapy in Pediatric Patients with Congenital Adrenal Hyperplasia.
Melin J; Parra-Guillen ZP; Michelet R; Truong T; Huisinga W; Hartung N; Hindmarsh P; Kloft C
J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 32052005
[TBL] [Abstract][Full Text] [Related]
4. Scalp hair 17-hydroxyprogesterone and androstenedione as a long-term therapy monitoring tool in congenital adrenal hyperplasia.
Noppe G; de Rijke YB; Koper JW; van Rossum EF; van den Akker EL
Clin Endocrinol (Oxf); 2016 Oct; 85(4):522-7. PubMed ID: 27061431
[TBL] [Abstract][Full Text] [Related]
5. Reverse circadian glucocorticoid treatment in prepubertal children with congenital adrenal hyperplasia.
Dubinski I; Bechtold Dalla-Pozza S; Bidlingmaier M; Reisch N; Schmidt H
J Pediatr Endocrinol Metab; 2021 Dec; 34(12):1543-1548. PubMed ID: 34523293
[TBL] [Abstract][Full Text] [Related]
6. Monitoring congenital adrenal hyperplasia using blood spot 17-hydroxyprogesterone assay.
Santos CM; Abad LR; Cua SC; Domingo CF
Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():174-8. PubMed ID: 15906729
[TBL] [Abstract][Full Text] [Related]
7. Steroid profiling for congenital adrenal hyperplasia by tandem mass spectrometry as a second-tier test reduces follow-up burdens in a tertiary care hospital: a retrospective and prospective evaluation.
Seo JY; Park HD; Kim JW; Oh HJ; Yang JS; Chang YS; Park WS; Lee SY
J Perinat Med; 2014 Jan; 42(1):121-7. PubMed ID: 23989111
[TBL] [Abstract][Full Text] [Related]
8. Comparison of multiple steroid concentrations in serum and dried blood spots throughout the day of patients with congenital adrenal hyperplasia.
Sarafoglou K; Himes JH; Lacey JM; Netzel BC; Singh RJ; Matern D
Horm Res Paediatr; 2011; 75(1):19-25. PubMed ID: 20798478
[TBL] [Abstract][Full Text] [Related]
9. Advancement in steroid hormone analysis by LC-MS/MS in clinical routine diagnostics - A three year recap from serum cortisol to dried blood 17α-hydroxyprogesterone.
Gaudl A; Kratzsch J; Ceglarek U
J Steroid Biochem Mol Biol; 2019 Sep; 192():105389. PubMed ID: 31158444
[TBL] [Abstract][Full Text] [Related]
10. Correlation of blood-spot 17-hydroxyprogesterone daily profiles and urinary steroid profiles in congenital adrenal hyperplasia.
Erhardt E; Sólyom J; Homoki J; Juricskay S; Soltész G
J Pediatr Endocrinol Metab; 2000 Feb; 13(2):205-10. PubMed ID: 10711668
[TBL] [Abstract][Full Text] [Related]
11. Newborn screening for congenital adrenal hyperplasia: additional steroid profile using liquid chromatography-tandem mass spectrometry.
Janzen N; Peter M; Sander S; Steuerwald U; Terhardt M; Holtkamp U; Sander J
J Clin Endocrinol Metab; 2007 Jul; 92(7):2581-9. PubMed ID: 17456574
[TBL] [Abstract][Full Text] [Related]
12. Liquid chromatography-tandem mass spectrometry analysis of 17-hydroxyprogesterone in dried blood spots revealed matrix effect on immunoassay.
Han L; Tavakoli NP; Morrissey M; Spink DC; Cao ZT
Anal Bioanal Chem; 2019 Jan; 411(2):395-402. PubMed ID: 30456606
[TBL] [Abstract][Full Text] [Related]
13. Blood-spot 17 alpha-hydroxyprogesterone radioimmunoassay in the follow-up of congenital adrenal hyperplasia.
Sólyom J
Clin Endocrinol (Oxf); 1981 Jun; 14(6):547-53. PubMed ID: 7296904
[TBL] [Abstract][Full Text] [Related]
14. Bloodspot 17 alpha-hydroxyprogesterone radioimmunoassay for diagnosis of congenital adrenal hyperplasia and home monitoring of corticosteroid replacement therapy.
Riordan FA; Wood PJ; Wakelin K; Betts P; Clayton BE
Lancet; 1984 Mar; 1(8379):708-11. PubMed ID: 6143043
[TBL] [Abstract][Full Text] [Related]
15. Functional glucocorticoid receptor gene variants do not underlie the high variability of 17-hydroxyprogesterone screening values in healthy newborns.
Schreiner F; Tozakidou M; Maslak R; Holtkamp U; Peter M; Gohlke B; Woelfle J
Eur J Endocrinol; 2009 Apr; 160(4):667-73. PubMed ID: 19174530
[TBL] [Abstract][Full Text] [Related]
16. Multiplexed steroid profiling of gluco- and mineralocorticoids pathways using a liquid chromatography tandem mass spectrometry method.
Travers S; Martinerie L; Bouvattier C; Boileau P; Lombès M; Pussard E
J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt B):202-211. PubMed ID: 27339652
[TBL] [Abstract][Full Text] [Related]
17. [Salivary 17-hydroxyprogesterone concentration in monitoring of the treatment of congenital adrenal hyperplasia].
Arisaka O; Shimura N; Nakayama Y; Arisaka M; Yabuta K
Dtsch Med Wochenschr; 1988 Dec; 113(49):1913-5. PubMed ID: 3197614
[TBL] [Abstract][Full Text] [Related]
18. [Determination of serum steroids in monitoring therapy of congenital adrenal hyperplasia].
Xiao HW; Ma HM; Su Z; Du ML; Li YH; Chen HS; Chen QL
Zhonghua Er Ke Za Zhi; 2012 Apr; 50(4):301-7. PubMed ID: 22801236
[TBL] [Abstract][Full Text] [Related]
19. Cortisol in dried blood screening specimens from newborns with raised 17-hydroxyprogesterone and congenital adrenal hyperplasia.
Mitchell ML; Hermos RJ
Clin Endocrinol (Oxf); 1998 Jun; 48(6):757-60. PubMed ID: 9713565
[TBL] [Abstract][Full Text] [Related]
20. Correlation between androstenedione and 17-hydroxyprogesterone levels in the saliva and plasma of patients with congenital adrenal hyperplasia.
Juniarto AZ; Goossens K; Setyawati BA; Drop SL; de Jong FH; Faradz SM
Singapore Med J; 2011 Nov; 52(11):810-3. PubMed ID: 22173250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
